Daily Archives: November 22, 2015
Early Detection of Alcoholic Liver Disease: Are We a Step Closer?
Alcoholic liver disease (ALD) is a growing cause of liver-related morbidity and mortality worldwide.1 Rates of hazardous drinking are increasing,2 the age of onset of drinking is decreasing, and more women are drinking heavily.2 With better control of … Continue reading
Posted in News
Comments Off on Early Detection of Alcoholic Liver Disease: Are We a Step Closer?
Combination of Pegylated Interferon and Tenofovir for Hepatitis B Treatment: Screening and Counseling of Patients are Warranted
Chronic hepatitis B virus (HBV) infection is a significant cause of global morbidity and mortality, primarily owing to liver cirrhosis and hepatocellular carcinoma (HCC). There are an estimated 240 million persons worldwide with chronic HBV.1 Universal… Continue reading
Posted in News
Comments Off on Combination of Pegylated Interferon and Tenofovir for Hepatitis B Treatment: Screening and Counseling of Patients are Warranted
The Morbidity and Mortality Conference in Gastroenterology and Hepatology: An Important Cornerstone of Patient Safety and Optimal Care
The morbidity and mortality (M&M) conference has evolved considerably in recent years. M&M was originally developed by surgeons and anesthesiologists to investigate negative “end results.”1 M&Ms were intended to be an open discussion of error and h… Continue reading
Posted in News
Comments Off on The Morbidity and Mortality Conference in Gastroenterology and Hepatology: An Important Cornerstone of Patient Safety and Optimal Care
AGA Institute Guideline on the Management of Microscopic Colitis: Clinical Decision Support Tool
Posted in News
Comments Off on AGA Institute Guideline on the Management of Microscopic Colitis: Clinical Decision Support Tool
The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in “Site”?
One of the major remaining mysteries about the pathogenesis of hepatitis B virus (HBV) infection is how the host immune system resolves the virus infection and eliminates the nuclear form of the viral genome, the covalently closed circular (ccc)DNA. T… Continue reading
Posted in News
Comments Off on The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in “Site”?
Early Detection of Alcoholic Liver Disease: Are We a Step Closer?
Alcoholic liver disease (ALD) is a growing cause of liver-related morbidity and mortality worldwide.1 Rates of hazardous drinking are increasing,2 the age of onset of drinking is decreasing, and more women are drinking heavily.2 With better control of … Continue reading
Posted in News
Comments Off on Early Detection of Alcoholic Liver Disease: Are We a Step Closer?
Combination of Pegylated Interferon and Tenofovir for Hepatitis B Treatment: Screening and Counseling of Patients are Warranted
Chronic hepatitis B virus (HBV) infection is a significant cause of global morbidity and mortality, primarily owing to liver cirrhosis and hepatocellular carcinoma (HCC). There are an estimated 240 million persons worldwide with chronic HBV.1 Universal… Continue reading
Posted in News
Comments Off on Combination of Pegylated Interferon and Tenofovir for Hepatitis B Treatment: Screening and Counseling of Patients are Warranted
The Morbidity and Mortality Conference in Gastroenterology and Hepatology: An Important Cornerstone of Patient Safety and Optimal Care
The morbidity and mortality (M&M) conference has evolved considerably in recent years. M&M was originally developed by surgeons and anesthesiologists to investigate negative “end results.”1 M&Ms were intended to be an open discussion of error and h… Continue reading
Posted in News
Comments Off on The Morbidity and Mortality Conference in Gastroenterology and Hepatology: An Important Cornerstone of Patient Safety and Optimal Care
AGA Institute Guideline on the Management of Microscopic Colitis: Clinical Decision Support Tool
Posted in News
Comments Off on AGA Institute Guideline on the Management of Microscopic Colitis: Clinical Decision Support Tool
The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in “Site”?
One of the major remaining mysteries about the pathogenesis of hepatitis B virus (HBV) infection is how the host immune system resolves the virus infection and eliminates the nuclear form of the viral genome, the covalently closed circular (ccc)DNA. T… Continue reading
Posted in News
Comments Off on The Covalently Closed Circular Form of Hepatitis B Virus Genome: Is There Now an End in “Site”?